Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

This study aimed to quantify self-stigma, explore some aspects of perceived stigma, determine the factors associated with greater self-stigma and examine whether the level of self-stigma was relate

Original research | 2024
About PWUD, Barriers and enablers, Hesitancy of prescribers , Hospitals, Opioids, Stigma, Substitution/OAT, Treatment/recovery

Identifying the most effective state laws and provisions to reduce opioid overdose deaths remains critical.

Original research | 2025
Harm reduction, Overdose, Opioids, Policy/Regulatory

Infrastructural violence ensues when infrastructure is designed for some members or groups within a society while perpetuating violence among others.

Original research | 2025
About people who use drugs, Barriers and enablers, Equity, Hesitancy of prescribers , Hospitals, Injecting drugs, Stigma, Substitution/OAT

This research examines how nurses' talk and institutional texts discursively construct social justice within the institutional context of the emergency department, and how such discourses shape the

Original research | 2024
About nurses, Barriers and enablers, Chronic disease, Equity, Harm reduction, Hospitals, Illegal drugs, Indigenous, Overdose, Policy/Regulatory, Stigma, Transitions in care/treatment

This study sought to understand the specific characteristics and operations of harm reduction housing (HRH) in Boston to generate a comprehensive inventory tool for evaluating implementation of har

Original research | 2025
Harm reduction, Housing, Illegal drugs, Injecting drugs, Overdose, Policy/Regulatory, SCS/OPS, Stigma, Transitions in care/treatment, Wrap-around services
Commentary | 2025
About pharmacists, Advocacy, Barriers and enablers, Decriminalization/legalization, Harm reduction, Injecting drugs, Overdose, SCS/OPS, Social benefits, Social services, Wrap-around services

To assess real-world access to buprenorphine treatment in Philadelphia and measure adoption of policies and practices that facilitate buprenorphine access.

Original research | 2025
Barriers and enablers, Policy/Regulatory, Substitution/OAT, Treatment/recovery

This commentary is concerned with buprenorphine treatment for individuals with opioid use disorder in the fentanyl era.

Commentary | 2025
Barriers and enablers, Illegal drugs, Overdose, Policy/Regulatory, Stimulants, Substitution/OAT, Withdrawal, Treatment/recovery

The rise of high-potency opioids such as fentanyl makes buprenorphine initiation challenging due to the risks of precipitated withdrawal, prompting the exploration of strategies, such as low-dose i

Original research | 2025
Housing, Illegal drugs, Overdose, Outcomes, Substitution/OAT, Treatment/recovery

Ongoing law enforcement strategies to disrupt local unregulated drug markets can have an iatrogenic effect of increasing overdose by driving consumers towards new suppliers with unpredictable drug

Original research | 2025
Advocacy, Barriers and enablers, Decriminalization/legalization, Equity, Harm reduction, Illegal drugs, Legal system/law enforcement, Mortality, Overdose, Poverty

This study assesses the prevalence and correlates of chronic pain among primary fentanyl users.

Original research | 2024
Advocacy, About PWUD, Barriers and enablers, Chronic pain, Illegal drugs, Opioids, Substitution/OAT

A growing body of research details the impacts of COVID-19 pandemic-related public health directives and service disruptions on people who use unregulated drugs, however, there is limited research

Original research | 2025
About PWUD, Barriers and enablers, Equity, Illegal drugs, Harm reduction, Legal system/law enforcement, Overdose, Parents/caregivers, Sex/Gender , Stigma

This paper discusses the unique risk profile of potent, synthetic illegal drugs being packaged as counterfeit pills (as opposed to powder) in the context of overdose crises like those seen in North

Perspective | 2025
Illegal drugs, Diversion, Drug checking, Harm reduction, Overdose, Safer supply, Stigma, Substitution/OAT

People exposed to fentanyl may report that the dose of methadone in the commonly accepted therapeutic range feels too low. This paper examines self-reported methadone dose adequacy.

Original research | 2025
Advocacy, About PWUD, Illegal drugs, Opioids, Peer/PWLLE program involvement, Substitution/OAT, Withdrawal

This study examines the recent proliferation of manslaughter charges and subsequent prosecutions brought against people who have shared, sold, or provided drugs that have led to overdose death in C

Original research | 2024
Advocacy, About people who sell drugs, About PWUD, Decriminalization/legalization, Crime, Legal system/law enforcement, Policy/Regulatory, Overdose
Report | 2025
Benzodiazepines, Drug checking, Illegal drugs, Opioids, Overdose, Stimulants, Xylazine
Guidelines | 2024
About prescribers, Chronic pain, Clinical guidance, Mental health, Opioids, Overdose

Summarizes the Timmins Summit, held in partnership with the City of Timmins.

Report | 2024
Barriers and enablers, Housing, Illegal drugs, Legal system/law enforcement, Overdose, Policy/Regulatory, Small/medium cities, Stigma, Treatment/recovery

This paper describes the results of retrospective Safer Stimulant Supply program medical chart reviews.

Original research | 2025
Advocacy, Harm reduction, Housing, Illegal drugs, Injecting drugs, Safer supply, Social benefits, Stimulants, Wrap-around services

CCENDU, co-ordinated by the CCSA, publishes this newsletter regularly to inform people living in Canada about emerging substance use issues and trends.

Newsletter | 2025
Benzodiazepines, Drug checking, Harm reduction, Illegal drugs, Overdose, Withdrawal, Substitution/OAT

Refine Your Search

Keywords
Format
Region